UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 684

Sortiert nach

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S79-S94

2019

Volltextzugriff (PDF)

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Volltextzugriff (PDF)

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

International journal of antimicrobial agents, 2020-01, Vol.55 (1), p.105799-105799, Article 105799

2020

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S47-S53

2019

Volltextzugriff (PDF)

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Future microbiology, 2016-01, Vol.11 (1), p.103-117

2016

Volltextzugriff (PDF)

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

International journal of antimicrobial agents, 2011-07, Vol.38 (1), p.65-69

2011

Volltextzugriff (PDF)

Analysis of Candida auris fungemia at a single facility in Kenya

International journal of infectious diseases, 2019-08, Vol.85, p.182-187

2019

Volltextzugriff (PDF)

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.117-127

2021

Volltextzugriff (PDF)

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.371-377

2022

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

The Brazilian journal of infectious diseases, 2017-11, Vol.21 (6), p.627-637

2017

Volltextzugriff (PDF)

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Clinical infectious diseases, 2001-07, Vol.33 (2), p.177-186

2001

Volltextzugriff (PDF)

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.239-244

1999

Volltextzugriff (PDF)

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

Journal of global antimicrobial resistance., 2020-12, Vol.23, p.278-283

2020

Volltextzugriff (PDF)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Volltextzugriff (PDF)

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10)

2017

Volltextzugriff (PDF)

Characterization of biofilms formed by Candida parapsilosis , C. metapsilosis , and C. orthopsilosis

International journal of medical microbiology, 2010-04, Vol.300 (4), p.265-270

2010

Volltextzugriff (PDF)

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

Infection control and hospital epidemiology, 2006-12, Vol.27 (12), p.1291

2006

Volltextzugriff (PDF)

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2868-2873

2016

Volltextzugriff (PDF)

In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018

Antimicrobial agents and chemotherapy, 2019-11, Vol.63 (11)

2019

Volltextzugriff (PDF)

In Candida albicans, White-Opaque Switchers Are Homozygous for Mating Type

Genetics (Austin), 2002-10, Vol.162 (2), p.737-745

2002

Volltextzugriff (PDF)

Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012–2017)

Diagnostic microbiology and infectious disease, 2020-06, Vol.97 (2), p.115016-115016, Article 115016

2020

Volltextzugriff (PDF)

Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011–2016)

International journal of antimicrobial agents, 2018-04, Vol.51 (4), p.608-611

2018

Volltextzugriff (PDF)

1 – 25 von 684

Suche als RSS-Feed

Aktive Filter

ThemaMicrobial Sensitivity Tests

ThemaMycology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(458)
Mit Volltextzugriff
(570)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(313)
Life Sciences & Biomedicine
(294)
Humans
(196)
Microbiology
(175)
Infectious Diseases
(174)
Biological And Medical Sciences
(163)
Medical Sciences
(131)
Pharmacology. Drug Treatments
(64)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(60)
Fundamental And Applied Biological Sciences. Psychology
(58)
Infections
(51)
Male
(51)
Bacteriology
(50)
Animals
(49)
Epidemiology
(47)
Female
(47)
Immunology
(46)
Antibacterial Agents
(45)
Infectious Disease
(44)
Pharmacology & Pharmacy
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Analysis of Candida auris fungemia at a single facility in Kenya

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans

Characterization of biofilms formed by Candida parapsilosis , C. metapsilosis , and C. orthopsilosis

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018

In Candida albicans, White-Opaque Switchers Are Homozygous for Mating Type

Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012–2017)

Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011–2016)

Aktive Filter

Suchergebnisse filtern